
### [Orphanet:385](http://www.orpha.net/ORDO/Orphanet_385)
**Label:** Neurodegeneration with brain iron accumulation

**Subclasses:** [Orphanet:157850](http://www.orpha.net/ORDO/Orphanet_157850) (Pantothenate kinase-associated neurodegeneration), [Orphanet:329284](http://www.orpha.net/ORDO/Orphanet_329284) (Beta-propeller protein-associated neurodegeneration), [Orphanet:48818](http://www.orpha.net/ORDO/Orphanet_48818) (Aceruloplasminemia), [Orphanet:306674](http://www.orpha.net/ORDO/Orphanet_306674) (Kufor-Rakeb syndrome), [Orphanet:157846](http://www.orpha.net/ORDO/Orphanet_157846) (Neuroferritinopathy), [Orphanet:3464](http://www.orpha.net/ORDO/Orphanet_3464) (Woodhouse-Sakati syndrome), [Orphanet:289560](http://www.orpha.net/ORDO/Orphanet_289560) (Mitochondrial membrane protein-associated neurodegeneration), [Orphanet:397725](http://www.orpha.net/ORDO/Orphanet_397725) (COASY protein-associated neurodegeneration), 

**Corr. equiv. classes:** [Orphanet:397725](http://www.orpha.net/ORDO/Orphanet_397725), [OMIM:606159](http://purl.obolibrary.org/obo/OMIM_606159), [OMIM:241080](http://purl.obolibrary.org/obo/OMIM_241080), [Orphanet:157846](http://www.orpha.net/ORDO/Orphanet_157846), [Orphanet:157850](http://www.orpha.net/ORDO/Orphanet_157850), [OMIM:300894](http://purl.obolibrary.org/obo/OMIM_300894), [Orphanet:289560](http://www.orpha.net/ORDO/Orphanet_289560), [Orphanet:306674](http://www.orpha.net/ORDO/Orphanet_306674), [OMIM:615643](http://purl.obolibrary.org/obo/OMIM_615643), [OMIM:614298](http://purl.obolibrary.org/obo/OMIM_614298), [Orphanet:48818](http://www.orpha.net/ORDO/Orphanet_48818), [OMIM:604290](http://purl.obolibrary.org/obo/OMIM_604290), [Orphanet:329284](http://www.orpha.net/ORDO/Orphanet_329284), [OMIM:606693](http://purl.obolibrary.org/obo/OMIM_606693), [Orphanet:3464](http://www.orpha.net/ORDO/Orphanet_3464), [OMIM:234200](http://purl.obolibrary.org/obo/OMIM_234200), 

**Class expressions from DL-Learner:**

- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) 62.50%
- [HP:0001268](http://purl.obolibrary.org/obo/HP_0001268) (Mental deterioration) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) 62.50%
- [HP:0001257](http://purl.obolibrary.org/obo/HP_0001257) (Spasticity) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) 62.50%
- [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 62.50%
- [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 62.50%
- [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) 62.50%
- [HP:0002493](http://purl.obolibrary.org/obo/HP_0002493) (Upper motor neuron dysfunction) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) 62.50%
- [HP:0002167](http://purl.obolibrary.org/obo/HP_0002167) (Neurological speech impairment) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) 62.50%
- [HP:0002071](http://purl.obolibrary.org/obo/HP_0002071) (Abnormality of extrapyramidal motor function) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) 62.50%
- [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) 62.50%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) and [HP:0100543](http://purl.obolibrary.org/obo/HP_0100543) (Cognitive impairment) 62.50%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 62.50%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0011446](http://purl.obolibrary.org/obo/HP_0011446) (Abnormality of higher mental function) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) 62.50%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0002167](http://purl.obolibrary.org/obo/HP_0002167) (Neurological speech impairment) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) 62.50%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) and [HP:0002071](http://purl.obolibrary.org/obo/HP_0002071) (Abnormality of extrapyramidal motor function) and [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0012179](http://purl.obolibrary.org/obo/HP_0012179) (Craniofacial dystonia) 62.50%


